18.07.2016 • News

DuPont Critics Warn Ahead of Merger Meeting

(c) zoranm/Getty Images
(c) zoranm/Getty Images

Keep Your Promises DuPont, a pressure group that bills itself as a “community-based organization seeking to hold DuPont accountable to the people of the Greater Mid-Ohio Valley area” has written to the boards of directors of DuPont and Dow Chemical demanding that the companies remedy what it sees as “a number of inadequate or misleading disclosures in the companies’ joint merger proxy and “ensure that their shareholders are provided the requisite disclosures so as to allow them to vote their shares at the special meetings scheduled for Jul. 20, 2016.

At the separate meetings, shareholders of the two parties to the potential merger are due to vote on how to proceed. The disclosures referred to concern “the mounting liabilities” connected to PFOA (C8) and other contaminated sites, and “we do not think that shareholders should be left in the dark," said Jeffrey Dugas, campaign manager for Keep Your Promises DuPont, adding: "If DuPont and Dow have nothing to hide, they should come clean before shareholders vote on the merger next week."

DuPont is facing around 3,500 lawsuits from people who claim they or their family members suffered health problems from drinking water contaminated with C8 produced in the company’s Washington Works in West Virginia.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read